Results 181 to 190 of about 121,553 (350)

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

A case of designer drug (cathinone) poisoning

, 2017
Takasei Morioka, Tomonori YAMAMOTO, Shinichiro Kaga, Tetsuro Nishimura, Hiromasa Yamamoto, Yasumitsu Mizobata, Taro Shimono   +6 more
openalex   +2 more sources

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Identification and Structural Elucidation of a Novel Pyrrolidinophenone-Based Designer Drug on the Illicit Market: α-BPVP. [PDF]

Chem Res Toxicol
Casati S, Bergamaschi RF, Primavera R, Ravelli A, Lavota I, Battistini A, Roda G, Ciccarelli C, Guidotti C, Rota P.   +9 more
europepmc   +1 more source

An In Vitro Study of the Neurotoxic Effects of N-Benzylpiperazine: A Designer Drug of Abuse. [PDF]

Neurotox Res, 2016
Persona K, Polus A, Góralska J, Gruca A, Dembińska-Kieć A, Piekoszewski W.   +5 more
europepmc   +1 more source

PRODUCING OR MARKETING THE DESIGNER DRUGS AS AN OFFENCE FRoM ARTICLE 165 § 1 POINT 2 CC [PDF]

, 2018
Magdalena Kowalewska-Łukuć
openalex   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug. [PDF]

Psychopharmacology (Berl)
Ramaekers JG, Reckweg JT, Mason NL, Kuypers KP, Toennes SW, Theunissen EL.   +5 more
europepmc   +1 more source

Chiral resolution and absolute configuration of the enantiomers of the psychoactive "designer drug" 3,4-methylenedioxypyrovalerone. [PDF]

Chirality, 2015
Suzuki M, Deschamps JR, Jacobson AE, Rice KC.   +3 more
europepmc   +1 more source

Designer Tridentate Mucin 1 Aptamer for Targeted Drug Delivery

, 2012
Lihan Tan, K. G. Neoh, E. T. Kang, Woo‐Seok Choe, Xiaodi Su   +4 more
openalex   +2 more sources